Amrize AG (SWX:AMRZ)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 17.88B -25.6% |
| Revenue (ttm) | 9.84B +5.0% |
| Net Income | 997.88M +5.8% |
| EPS | 1.80 +6.1% |
| Shares Out | 546.93M |
| PE Ratio | 18.16 |
| Forward PE | 14.34 |
| Dividend | 0.36 (1.02%) |
| Ex-Dividend Date | Aug 18, 2026 |
| Volume | 439,367 |
| Open | 32.93 |
| Previous Close | 32.70 |
| Day's Range | 32.89 - 33.24 |
| 52-Week Range | 32.58 - 51.34 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 46.51 (+40.3%) |
| Earnings Date | Oct 26, 2026 |
About Amrize AG
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coating... [Read more]
Financial Performance
In 2025, Amrize AG's revenue was $11.82 billion, an increase of 0.95% compared to the previous year's $11.70 billion. Earnings were $1.19 billion, a decrease of -6.99%.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for AMRZ stock is "Buy." The 12-month stock price target is CHF 46.51, which is an increase of 40.30% from the latest price.
News
Amrize downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Amrize (AMRZ) to Equal Weight from Overweight with a price target of $44, down from $55. The firm downgraded three names in construction materials citing an “increasingly…
Amrize downgraded to Underperform from Neutral at BofA
BofA downgraded Amrize (AMRZ) to Underperform from Neutral with a price target of $40, down from $50. The firm cut the company’s estimates citing its slower growth outlook. Amrize’s growth…
Amrize downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Amrize (AMRZ) to Neutral from Overweight with a price target of $52, down from $57. The firm believes it will take some time for investors to regain confidence…
3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
The bond market continues to flash warning signs as the Trump administration expands its trade war, and no, you haven't entered a time machine and returned to April 2025. This time, it's the Section 3...
Amrize Chief Strategy Officer Buys 2,510 Shares in $117,769 Transaction
The purchase involved 2,510 shares at $46.92 per share. The shares were acquired directly, with no reported indirect holdings or derivative conversions.
Amrize Ltd (AMRZ) Insider Buying: Chief Marketing & Corporate Affairs Officer Nollaig ...
Amrize Ltd (AMRZ) Insider Buying: Chief Marketing & Corporate Affairs Officer Nollaig Forrest Purchases 1,500 Shares
Amrize (AMRZ) Names Samuel J. Poletti as CFO Amid Strategic Leadership Shift
Amrize (AMRZ) Names Samuel J. Poletti as CFO Amid Strategic Leadership Shift
Amrize initiated with a Neutral at DA Davidson
DA Davidson initiated coverage of Amrize (AMRZ) with a Neutral rating and $50 price target The company’s visibility to positive catalysts remains limited over the next several quarters, the analyst…
Amrize names Sam Poletti CFO
Amrize’s (AMRZ) board of directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company…
Amrize Appoints Sam Poletti as Chief Financial Officer
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, wh...
Amrize price target lowered to $50 from $60 at BofA
BofA analyst Arnaud Lehmann lowered the firm’s price target on Amrize (AMRZ) to $50 from $60 and keeps a Neutral rating on the shares.
Amrize price target lowered to $54 from $65 at Stephens
Stephens lowered the firm’s price target on Amrize (AMRZ) to $54 from $65 and keeps an Overweight rating on the shares. Investors “could take a wait and see approach,” but…
Amrize (AMRZ) Q2 2026 Earnings Call Transcript
Data center demand lifts cement and roofing volumes as oil inflation pressures margins.
Amrize price target lowered to $58 from $66 at Citi
Citi lowered the firm’s price target on Amrize (AMRZ) to $58 from $66 and keeps a Buy rating on the shares.
Amrize Files Form 10-Q for Second Quarter 2026
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) has filed its Form 10-Q for the Second Quarter and First Half Year 2026 with the U.S. Securities and Exchange Commission. The report is also ...
RBC Downgrades Amrize (AMRZ) Amid Profit Growth Concerns; Valuation and Insider Activity Under ...
RBC Downgrades Amrize (AMRZ) Amid Profit Growth Concerns; Valuation and Insider Activity Under the Spotlight
Amrize downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital downgraded Amrize (AMRZ) to Underperform from Sector Perform with a price target of $48, down from $60. The firm says Amrize is only major heavy-side building materials name…
Amrize Ltd (AMRZ) Reports Strong Q2 Growth Amid Mixed Valuation Signals
Amrize Ltd (AMRZ) Reports Strong Q2 Growth Amid Mixed Valuation Signals
Amrize Q2 Earnings Call Highlights
Amrize NYSE: AMRZ reported second-quarter revenue growth of 8.6%, supported by demand from large commercial, infrastructure, energy and advanced-manufacturing projects, while higher freight, diesel an...
Amrize AG Earnings Call Transcript: Q2 2026
Revenue grew 8.6% and net income rose 14.4% year-over-year, driven by strong demand in mega projects and infrastructure. Adjusted EBITDA increased 5.8%, with robust volume and pricing in key segments, despite cost inflation. Full-year guidance was raised for both revenue and EBITDA.
Amrize AG Slides: Q2 2026
Amrize AG has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Amrize AG Quarterly report: Q2 2026
Amrize AG has published its Q2 2026 quarterly earnings report on August 7, 2026.
Amrize AG Earnings release: Q2 2026
Amrize AG released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Amrize Ltd (AMRZ) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Amrize Ltd (AMRZ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare...
Amrize Reports Second Quarter 2026 Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its second quarter 2026 financial results1. Jan Jenisch, Chairman and CEO: "We delivered strong revenue growth of 8.6% in the...